📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? (2021)

First Author: Stachulski AV

Attributed to: Rational Design, Synthesis and Biological Evaluation of Benzimidazoles; Towards a Novel Therapy Selectively Targeting C. neoformans beta-tubulin funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acsinfecdis.0c00478

PubMed Identifier: 33352056

Publication URI: http://europepmc.org/abstract/MED/33352056

Type: Journal Article/Review

Volume: 7

Parent Publication: ACS infectious diseases

Issue: 6

ISSN: 2373-8227